Abstract
Biopharmaceutical research and development is sure to dramatically increase
the number of injectable drugs coming to market over the next few years. While
advanced drug delivery techniques continue to hold promise for unique methods
of administration, the traditional injection is still the dominant paradigm.
However, the staggering costs and intransigent safety problems associated with
sharps, along with consumer demand and the move to alternate-site care, are
pushing for alternatives to traditional needles and syringes faster than
advanced delivery technologies can come online.
The alternative in the short term appears to be the growing industry of
needle-free injection and safety-engineered syringes. These devices, ranging
from simple sheathed safety needles to complex gas jet injection systems, are
competing in a vigorous marketplace, some sectors of which are growing at an
annual rate in excess of 20%.
This report analyzes the current world market for needle-free drug delivery
injection systems and safety syringes in terms of dollar volume and unit sales
and makes forecasts through 2009. Regional geographic segmentations are also
provided through the forecast period in both units and dollars. The report
discusses the market's drivers and constraints and provided pertinent data on
the epidemiology of needlestick injuries, the value of injectable drug
markets, and other related issues and trends. It also profiles more than 25
companies involved in marketing or developing these devices, including Antares
Pharma, Becton Dickinson, Bioject, D'Antonio Consultants International,
Retractable Technologies, Safety Syringes Inc., and Tyco Healthcare.
Market forecasts are based on an examination of current market conditions and
on investigations into the development of new products by key companies. The
information presented in this report is the result of data gathered from
company product literature and other corporate brochures and documents, as
well as information found in the scientific and trade press. In addition,
interviews were conducted with company executives, clinicians, researchers and
public health officials.
Table of Contents
- Chapter One: Executive Summary
- 1.1 Background and Perspective
- 1.2 Traditional Drug Delivery Systems
- 1.3 Need for Alternative Delivery Systems
- 1.4 Market Summary
- 1.4.1 Market Drivers
- 1.4.2 Market Challenges
- 1.4.3 Brief Market Forecast
- 1.5 Methodology
- Chapter Two: Introduction
- 2.1 Risk and Prevention
- 2.2 Overview of Different Drug Delivery Systems
- 2.2.1 Polymers and Biomaterials
- 2.2.2 Oral Drug Delivery Systems
- 2.2.3 Pulmonary Drug Delivery
- 2.2.4 Drug Eluting Stents
- 2.2.5 Percutaneous Drug Delivery
- 2.2.6 Ophthalmic Drug Delivery
- 2.2.7 Colloidal Drug Delivery
- 2.2.8 Site Specific Delivery
- 2.2.9 Needle-Free Delivery
- 2.2.10 Safety Syringes
- 2.3 Key Medicines for Delivery
- 2.3.1 Insulin
- 2.3.2 Human Growth Hormone
- 2.3.3 Vaccines
- 2.4 Alternatives to Needle Delivery of Drugs
- 2.4.1 Needle-Free Systems
- 2.4.2 Safety Syringes
- 2.5 Factors Driving Development
- 2.5.1 Epidemiology of Injuries
- 2.5.1 Epidemiology of Bloodborne Virus Transmission
- 2.5.1.1 Hepatitis B Virus
- 2.5.1.2 Hepatitis C Virus
- 2.5.1.3 HIV
- 2.5.3 Cost of Needlestick Injuries
- 2.5.4 Prevention Approaches
- 2.6 Challenges and Issues
- 2.7 Needle-Free and Safety Syringe Drug Delivery Research
- 2.7.1 Microscission
- 2.7.2 Evolving Vaccine Delivery Technologies
- 2.7.2.1 Auto-Disable Syringes
- 2.7.2.2 Monodose Prefilled Injection Devices
- 2.7.2.3 Needle-Free Injections
- 2.7.2.4 Thermostable Vaccines
- Chapter Three: Markets
- 3.1 Current Face of the Market
- 3.1.1 Safety and Cost as Major Drivers
- 3.1.2 Technology Development
- 3.1.5 Prefilled Devices and Non-Prefilled Devices.
- 3.1.4 Convenience and Compliance
- 3.1.5 Product Differentiation
- 3.1.6 Harm Reduction.
- 3.1.7 Opportunity
- 3.2 Human Growth Hormone
- 3.3 Insulin
- 3.4 Vaccines
- 3.4.1 Immunization Programs
- 3.4.2 Emerging Vaccines
- 3.4.3 Injection Concerns
- 3.5 Needlestick Injuries
- 3.6 Geographic Markets
- Chapter Four: Corporate Profiles
- 4.1 Antares Pharma Inc.
- 4.2 Aradigm Corp.
- 4.3 Becton, Dickinson and Co.
- 4.4 Bioject Medical Technologies Inc.
- 4.5 BioValve Technologies Inc.
- 4.6 Cambridge Biostability Ltd.
- 4.7 D'Antonio Consultants International
- 4.8 Eastland Medical Systems Ltd.
- 4.9 Equidyne Systems
- 4.10 First Principals Inc.
- 4.11 Med-Design Corp.
- 4.12 Medical House PLC
- 4.13 Medical International Technologies
- 4.14 Medisys PLC
- 4.15 National Medical Products Inc.
- 4.16 New Medical Technology
- 4.17 Norwood Abbey Ltd.
- 4.18 Retractable Technologies Inc.
- 4.19 Roche (F. Hoffmann-La Roche Ltd.)
- 4.20 Serono Inc.
- 4.21 Safety Syringes Inc.
- 4.22 Smiths Medical (Smiths Group)
- 4.23 Sunder Group
- 4.24 Tyco Healthcare
- 4.25 Unilife Medical Solutions Ltd.
- 4.26 Univec Ltd.
- List Of Exhibits
- Chapter One: Executive Summary
- Exhibit 1-1: Summary: World Market for Drugs Delivered by Needle-Free
Systems 2005-2009
- Exhibit 1-2: Summary: World Market for Needle-Free Drug Injectors
2005-2009
- Exhibit 1-3: World Market for Safety Syringes 2005-2009
- Chapter Two: Introduction
- Exhibit 2-1: Immunization Cost Analysis
- Exhibit 2-2: Adult Preventable Disease Statistics
- Exhibit 2-3: Advantages of Needle-Free Delivery
- Exhibit 2-4: Annual Injury Rates for Healthcare and Sanitary Service
Personnel from Sharps in Found Medical Waste
- Exhibit 2-5: Work Locations Where Fluid Exposures Occurred (NaSH 6/95 to
10/01)
- Exhibit 2-6: Circumstances Associated with Hollow-Bore Needle Injuries
(NaSH 6/95 to 12/01)
- Exhibit 2-7: Devices Involved in Percutaneous Injuries (NaSH)
- Exhibit 2-8: Infections Transmitted via Sharps, Injuries during Patient
Care and/or Laboratory/Autopsy
- Exhibit 2-9: Estimated Number of People Living with HIV 2000-2004
- Chapter Three: Markets
- Exhibit 3-1: Prevalence of Diabetes in the Seven Major World Healthcare
Markets by Type 2004-2014
- Exhibit 3-2: World Market for Syringes Dollar Volume 2005-2009
- Exhibit 3-3: World Market for Syringes Dollar Volume by Geographic
Region 2005-2009
- Exhibit 3-4: World Market for Syringes Unit Sales 2005-2009
- Exhibit 3-5: World Market for Syringes Unit Sales by Geographic Region
2005-2009
- Exhibit 3-6: World Market for Safety Syringes Dollar Volume 2005-2009
- Exhibit 3-7: World Market for Safety Syringes Dollar Volume by
Geographic Region 2005-2009
- Exhibit 3-8: World Market for Safety Syringes Unit Sales 2005-2009
- Exhibit 3-9: World Market for Safety Syringes Unit Sales by Geographic
Region 2005-2009
- Exhibit 3-10: Market Segments for Safety Syringes Percentage by
Distribution Channel
- Exhibit 3-11: Worldwide Safety Syringe Market Market Share of Leading
Competitors
- Exhibit 3-12: World Market for Drugs Delivered by Needle-Free Systems
2005-2009
- Exhibit 3-13: World Market for Needle-Free Drug Injectors Dollar Volume
2005-2009
- Exhibit 3-14: World Market for Needle-Free Drug Injectors Dollar Volume
by Geographic Region 2005-2009
- Exhibit 3-15: World Market for Needle-Free Drug Injectors Unit Sales
2005-2009
- Exhibit 3-16: World Market for Needle-Free Drug Injectors Unit Sales by
Geographic Region 2005-2009
- Exhibit 3-17: Status of Selected Needle-Free Injection Systems and
Safety Syringes
医療機器
その他のカテゴリ
FAQ